Society guideline links: Systemic sclerosis (scleroderma)

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

United States

●American Thoracic Society (ATS): An official clinical practice guideline for treatment of systemic sclerosis-associated interstitial lung disease – Evidence-based recommendations (2023)

●American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR): Classification criteria for systemic sclerosis (2013)

Europe

●Single Hub and Access point for paediatric Rheumatology in Europe (SHARE): Consensus-based recommendations for the management of juvenile systemic sclerosis (2021)

●European League Against Rheumatism (EULAR): Recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases, update (2019)

●European Dermatology Forum (EDF): S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin – Part 1: Localized scleroderma, systemic sclerosis, and overlap syndromes (2017)

●EULAR: Recommendations for the treatment of systemic sclerosis, update (2017)

●European Society for Blood and Marrow Transplantation (EBMT): Recommendations on cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation (2017)

●American College of Rheumatology (ACR)/EULAR: Classification criteria for systemic sclerosis (2013)

United Kingdom

●British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR): Guideline for the treatment of systemic sclerosis (2016)

Japan

●[In English] Japanese Dermatological Association (JDA): Diagnostic criteria, severity classification, and guidelines of localized scleroderma (2018)

●[In Japanese] JDA: Guideline for diagnostic criteria, severity classification, and treatment of localized scleroderma (2016)